Selected research
Market Structure
Global Soft Capsules Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Soft Capsules Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Soft Capsules Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Soft Capsules Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Soft Capsules Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Soft Capsules Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Soft Capsules Drugs include GSK, A&Z Pharmaceutical, Atrium Innovations, Blackmores, Boehringer Ingelheim, By-health, Chiesi, Nature Made and Sumitomo Dainippon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Soft Capsules Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Soft Capsules Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Soft Capsules Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Soft Capsules Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Soft Capsules Drugs Segment by Company
GSK
A&Z Pharmaceutical
Atrium Innovations
Blackmores
Boehringer Ingelheim
By-health
Chiesi
Nature Made
Sumitomo Dainippon
The Clorox Company
Vertex
AstraZeneca
Roche
Merck
Novartis
Teva
Abbott
Soft Capsules Drugs Segment by Type
Liquid Core Drugs
Semi-solid Core Drugs
Soft Capsules Drugs Segment by Application
Hospital Pharmacy
Retail Pharmacy
Soft Capsules Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soft Capsules Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Soft Capsules Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soft Capsules Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Soft Capsules Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Soft Capsules Drugs industry.
Chapter 3: Detailed analysis of Soft Capsules Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Soft Capsules Drugsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid Core Drugs
- Semi-solid Core Drugs
Applications
- Hospital Pharmacy
- Retail Pharmacy
Companies covered
- GSK
- A&Z Pharmaceutical
- Atrium Innovations
- Blackmores
- Boehringer Ingelheim
- By-health
- Chiesi
- Nature Made
- Sumitomo Dainippon
- The Clorox Company
- Vertex
- AstraZeneca
- Roche
- Merck
- Novartis
- Teva
- Abbott
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Soft Capsules Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Liquid Core Drugs
- 1.2.3 Semi-solid Core Drugs
- 1.3 Market Analysis by Application
- 1.3.1 Global Soft Capsules Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital Pharmacy
- 1.3.3 Retail Pharmacy
- 1.4 Global Market Growth Prospects
- 1.5 Global Soft Capsules Drugs Growth Trends by Region
- 1.5.1 Global Soft Capsules Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Soft Capsules Drugs Market Size by Region (2021-2026)
- 1.5.3 Soft Capsules Drugs Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Soft Capsules Drugs Market Dynamics
- 2.1 Soft Capsules Drugs Industry Trends
- 2.2 Soft Capsules Drugs Industry Drivers
- 2.3 Soft Capsules Drugs Industry Opportunities and Challenges
- 2.4 Soft Capsules Drugs Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Soft Capsules Drugs Revenue by Company (2021-2026)
- 3.2 Global Soft Capsules Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Soft Capsules Drugs Key Company Head office and Area Served
- 3.4 Global Soft Capsules Drugs Company, Product Type & Application
- 3.5 Global Soft Capsules Drugs Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Soft Capsules Drugs Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Soft Capsules Drugs Players Market Share by Revenue in 2025
- 3.6.3 2025 Soft Capsules Drugs Tier 1, Tier 2, and Tier 3
4 Soft Capsules Drugs Market by Type
- 4.1 Global Soft Capsules Drugs Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Soft Capsules Drugs Market Size by Type (2021-2032)
- 4.3 Global Soft Capsules Drugs Market Size Share by Type (2021-2032)
5 Soft Capsules Drugs Market by Application
- 5.1 Global Soft Capsules Drugs Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Soft Capsules Drugs Market Size by Application (2021-2032)
- 5.3 Global Soft Capsules Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 GSK
- 6.1.1 GSK Company Information
- 6.1.2 GSK Business Overview
- 6.1.3 GSK Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 GSK Soft Capsules Drugs Product Portfolio
- 6.1.5 GSK Recent Developments
- 6.2 A&Z Pharmaceutical
- 6.2.1 A&Z Pharmaceutical Company Information
- 6.2.2 A&Z Pharmaceutical Business Overview
- 6.2.3 A&Z Pharmaceutical Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 A&Z Pharmaceutical Soft Capsules Drugs Product Portfolio
- 6.2.5 A&Z Pharmaceutical Recent Developments
- 6.3 Atrium Innovations
- 6.3.1 Atrium Innovations Company Information
- 6.3.2 Atrium Innovations Business Overview
- 6.3.3 Atrium Innovations Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Atrium Innovations Soft Capsules Drugs Product Portfolio
- 6.3.5 Atrium Innovations Recent Developments
- 6.4 Blackmores
- 6.4.1 Blackmores Company Information
- 6.4.2 Blackmores Business Overview
- 6.4.3 Blackmores Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Blackmores Soft Capsules Drugs Product Portfolio
- 6.4.5 Blackmores Recent Developments
- 6.5 Boehringer Ingelheim
- 6.5.1 Boehringer Ingelheim Company Information
- 6.5.2 Boehringer Ingelheim Business Overview
- 6.5.3 Boehringer Ingelheim Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Boehringer Ingelheim Soft Capsules Drugs Product Portfolio
- 6.5.5 Boehringer Ingelheim Recent Developments
- 6.6 By-health
- 6.6.1 By-health Company Information
- 6.6.2 By-health Business Overview
- 6.6.3 By-health Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 By-health Soft Capsules Drugs Product Portfolio
- 6.6.5 By-health Recent Developments
- 6.7 Chiesi
- 6.7.1 Chiesi Company Information
- 6.7.2 Chiesi Business Overview
- 6.7.3 Chiesi Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Chiesi Soft Capsules Drugs Product Portfolio
- 6.7.5 Chiesi Recent Developments
- 6.8 Nature Made
- 6.8.1 Nature Made Company Information
- 6.8.2 Nature Made Business Overview
- 6.8.3 Nature Made Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Nature Made Soft Capsules Drugs Product Portfolio
- 6.8.5 Nature Made Recent Developments
- 6.9 Sumitomo Dainippon
- 6.9.1 Sumitomo Dainippon Company Information
- 6.9.2 Sumitomo Dainippon Business Overview
- 6.9.3 Sumitomo Dainippon Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Sumitomo Dainippon Soft Capsules Drugs Product Portfolio
- 6.9.5 Sumitomo Dainippon Recent Developments
- 6.10 The Clorox Company
- 6.10.1 The Clorox Company Company Information
- 6.10.2 The Clorox Company Business Overview
- 6.10.3 The Clorox Company Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 The Clorox Company Soft Capsules Drugs Product Portfolio
- 6.10.5 The Clorox Company Recent Developments
- 6.11 Vertex
- 6.11.1 Vertex Company Information
- 6.11.2 Vertex Business Overview
- 6.11.3 Vertex Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Vertex Soft Capsules Drugs Product Portfolio
- 6.11.5 Vertex Recent Developments
- 6.12 AstraZeneca
- 6.12.1 AstraZeneca Company Information
- 6.12.2 AstraZeneca Business Overview
- 6.12.3 AstraZeneca Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 AstraZeneca Soft Capsules Drugs Product Portfolio
- 6.12.5 AstraZeneca Recent Developments
- 6.13 Roche
- 6.13.1 Roche Company Information
- 6.13.2 Roche Business Overview
- 6.13.3 Roche Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Roche Soft Capsules Drugs Product Portfolio
- 6.13.5 Roche Recent Developments
- 6.14 Merck
- 6.14.1 Merck Company Information
- 6.14.2 Merck Business Overview
- 6.14.3 Merck Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Merck Soft Capsules Drugs Product Portfolio
- 6.14.5 Merck Recent Developments
- 6.15 Novartis
- 6.15.1 Novartis Company Information
- 6.15.2 Novartis Business Overview
- 6.15.3 Novartis Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Novartis Soft Capsules Drugs Product Portfolio
- 6.15.5 Novartis Recent Developments
- 6.16 Teva
- 6.16.1 Teva Company Information
- 6.16.2 Teva Business Overview
- 6.16.3 Teva Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Teva Soft Capsules Drugs Product Portfolio
- 6.16.5 Teva Recent Developments
- 6.17 Abbott
- 6.17.1 Abbott Company Information
- 6.17.2 Abbott Business Overview
- 6.17.3 Abbott Soft Capsules Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Abbott Soft Capsules Drugs Product Portfolio
- 6.17.5 Abbott Recent Developments
7 North America
- 7.1 North America Soft Capsules Drugs Market Size (2021-2032)
- 7.2 North America Soft Capsules Drugs Market Size by Type
- 7.2.1 North America Soft Capsules Drugs Market Size by Type (2021-2026)
- 7.2.2 North America Soft Capsules Drugs Market Size by Type (2027-2032)
- 7.2.3 North America Soft Capsules Drugs Market Share by Type (2021-2032)
- 7.3 North America Soft Capsules Drugs Market Size by Application
- 7.3.1 North America Soft Capsules Drugs Market Size by Application (2021-2026)
- 7.3.2 North America Soft Capsules Drugs Market Size by Application (2027-2032)
- 7.3.3 North America Soft Capsules Drugs Market Share by Application (2021-2032)
- 7.4 North America Soft Capsules Drugs Market Size by Country
- 7.4.1 North America Soft Capsules Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Soft Capsules Drugs Market Size by Country (2021-2026)
- 7.4.3 North America Soft Capsules Drugs Market Size by Country (2027-2032)
- 7.4.4 North America Soft Capsules Drugs Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Soft Capsules Drugs Market Size (2021-2032)
- 8.2 Europe Soft Capsules Drugs Market Size by Type
- 8.2.1 Europe Soft Capsules Drugs Market Size by Type (2021-2026)
- 8.2.2 Europe Soft Capsules Drugs Market Size by Type (2027-2032)
- 8.2.3 Europe Soft Capsules Drugs Market Share by Type (2021-2032)
- 8.3 Europe Soft Capsules Drugs Market Size by Application
- 8.3.1 Europe Soft Capsules Drugs Market Size by Application (2021-2026)
- 8.3.2 Europe Soft Capsules Drugs Market Size by Application (2027-2032)
- 8.3.3 Europe Soft Capsules Drugs Market Share by Application (2021-2032)
- 8.4 Europe Soft Capsules Drugs Market Size by Country
- 8.4.1 Europe Soft Capsules Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Soft Capsules Drugs Market Size by Country (2021-2026)
- 8.4.3 Europe Soft Capsules Drugs Market Size by Country (2027-2032)
- 8.4.4 Europe Soft Capsules Drugs Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Soft Capsules Drugs Market Size (2021-2032)
- 9.2 China Soft Capsules Drugs Market Size by Type
- 9.2.1 China Soft Capsules Drugs Market Size by Type (2021-2026)
- 9.2.2 China Soft Capsules Drugs Market Size by Type (2027-2032)
- 9.2.3 China Soft Capsules Drugs Market Share by Type (2021-2032)
- 9.3 China Soft Capsules Drugs Market Size by Application
- 9.3.1 China Soft Capsules Drugs Market Size by Application (2021-2026)
- 9.3.2 China Soft Capsules Drugs Market Size by Application (2027-2032)
- 9.3.3 China Soft Capsules Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Soft Capsules Drugs Market Size (2021-2032)
- 10.2 Asia Soft Capsules Drugs Market Size by Type
- 10.2.1 Asia Soft Capsules Drugs Market Size by Type (2021-2026)
- 10.2.2 Asia Soft Capsules Drugs Market Size by Type (2027-2032)
- 10.2.3 Asia Soft Capsules Drugs Market Share by Type (2021-2032)
- 10.3 Asia Soft Capsules Drugs Market Size by Application
- 10.3.1 Asia Soft Capsules Drugs Market Size by Application (2021-2026)
- 10.3.2 Asia Soft Capsules Drugs Market Size by Application (2027-2032)
- 10.3.3 Asia Soft Capsules Drugs Market Share by Application (2021-2032)
- 10.4 Asia Soft Capsules Drugs Market Size by Country
- 10.4.1 Asia Soft Capsules Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Soft Capsules Drugs Market Size by Country (2021-2026)
- 10.4.3 Asia Soft Capsules Drugs Market Size by Country (2027-2032)
- 10.4.4 Asia Soft Capsules Drugs Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Soft Capsules Drugs Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Soft Capsules Drugs Market Size by Type
- 11.2.1 South America, Middle East & Africa Soft Capsules Drugs Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Soft Capsules Drugs Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Soft Capsules Drugs Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Soft Capsules Drugs Market Size by Application
- 11.3.1 South America, Middle East & Africa Soft Capsules Drugs Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Soft Capsules Drugs Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Soft Capsules Drugs Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Soft Capsules Drugs Market Size by Country
- 11.4.1 South America, Middle East & Africa Soft Capsules Drugs Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Soft Capsules Drugs Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Soft Capsules Drugs Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Soft Capsules Drugs Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst